13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate)

Pneumococcal conjugate vaccine (13-valent) · Fosun Adagenvax Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate), covering 2024-10-01 to 2024-10-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants [Phase 3]

See pricing